Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
Dan FanJennifer MaAndrew C BellAndries H GroenKyrie S OlsenBenjamin H LokJonathan E LeemanErik AndersonNadeem RiazSean McBrideIan GanlyAshok R ShahaEric J ShermanC Jillian TsaiJung J KangNancy Y LeePublished in: Cancer (2019)
RT appears to demonstrate a dose-dependent, persistent LPFS and OS benefit in patients with locally advanced ATC with an acceptable toxicity profile. Aggressive RT should be strongly considered for the treatment of patients with ATC as part of a trimodal treatment approach.